Sona Nanotech Inc (TSE:SONA) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Sona Nanotech Inc. reports a breakthrough in its preclinical studies where its Targeted Hyperthermia Therapy, combined with immunotherapy, not only shrank primary tumors in mice but also eliminated untreated distant tumors, demonstrating a ‘vaccine effect’ with lasting immunity against cancer recurrence. The promising results, indicating potential for a novel cancer treatment, are propelling the company towards regulatory studies for human trials, targeting individuals with late-stage melanoma.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
